Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Gold Nanoparticles Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Water Soluble
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Oil Soluble
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Application
7.1 Imaging
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Targeted Drug Delivery
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sensors
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 In Vitro Diagnostics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Probes
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Catalysis
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast

8 Market Breakup by End-Use Industry
8.1 Electronics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Healthcare
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Chemicals
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 BBI Solutions
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cline Scientific
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cytodiagnostics
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Expedeon
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Goldsol
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Meliorum Technologies
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck Group
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Metalor Technologies International
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Nanocomposix
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 NanoHybrids
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Nanopartz
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Sigma-Aldrich
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.14 Solaris Nanosciences Corporation
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
14.3.15 Tanaka Kikinzoku
14.3.15.1 Company Overview
14.3.15.2 Product Portfolio